-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
VYNE Therapeutics Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2015 to 2024.
- VYNE Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$7.98M, a 45.7% decline year-over-year.
- VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$34M, a 34.1% decline from 2023.
- VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.3M, a 13.2% increase from 2022.
- VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$29.2M, a 48.2% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)